ArticleThe pharmacogenomics journal2017

FCGR3A-V158F polymorphism is a disease-specific pharmacogenetic marker for the treatment of psoriasis with Fc-containing TNFα inhibitors.

E Mendrinou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.